Sharon Kehoe

Dr. Sharon Kehoe


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2012 in Injury
Verified
Journal Article
Closed access
SKSharon Kehoe
Sharon Kehoe
XZX.F. Zhang
X.F. Zhang
DBD. Boyd
D. Boyd

3 August 2012 in Journal of Biomaterials Applications
Verified
Journal Article
Closed access
PDF file
SKSharon Kehoe
Sharon Kehoe
MLMaxine Langman
Maxine Langman
UWUlli Werner-Zwanziger
Ulli Werner-Zwanziger
RARobert J Abraham
Robert J Abraham
DBDaniel Boyd
Daniel Boyd
Embolization with micron-sized particulates is widely applied to treat uterine fibroids. The objective of this work was to develop mixture designs to predict materials composition–structure–property relationships for the SiO2–CaO–ZnO–La2O3–TiO2–MgO–SrO–Na2O glass system and compare its fundamental materials properties (density and cytocompatibility), against a state-of-the-art embolic agent (contour polyvinyl alcohol) to assess the potential of these materials for embolization therapies. The glass structures were evaluated using 29Si MAS NMR to identify chemical shift and line width; the particulate densities were determined using helium pycnometry and the cell viabilities were assessed via MTT assay. 29Si MAS NMR results indicated peak maxima for each glass in the range of −82.3 ppm to −89.9 ppm; associated with Q2 to Q3 units in silicate glasses. All experimental embolic compositions showed enhanced in vitro compatibility in comparison to Contour PVA with the exceptions of ORP9 and ORP11 (containing no TiO2). In this study, optimal compositions for cell viability were obtained for the following compositional ranges: 0.095–0.188 mole fraction ZnO; 0.068–0.159 mole fraction La2O3; 0.545–0.562 mole fraction SiO2 and 0.042–0.050 mole fraction TiO2. To ensure ease of producibility in obtaining good melts, a maximum loading of 0.068 mole fraction La2O3 is required. This is confirmed by the desirability approach, for which the only experimental composition (ORP5) of the materials evaluated was presented as an optimum composition; combining high cell viability with ease of production (0.188 mole fraction ZnO; 0.068 mole fraction La2O3; 0.562 mole fraction SiO2 and 0.042 mole fraction TiO2).

3 March 2011 in Journal of Materials Science: Materials in Medicine
Verified
Journal Article
Closed access
PDF file
SKSharon Kehoe
Sharon Kehoe
XZX. F. Zhang
X. F. Zhang
DBDaniel Boyd
Daniel Boyd

1 November 2012 in Materials Letters
Verified
Journal Article
Closed access
SKSharon Kehoe
Sharon Kehoe
NKN. Kilcup
N. Kilcup
DBD. Boyd
D. Boyd

1 October 2012 in Journal of the Mechanical Behavior of Biomedical Materials
Verified
Journal Article
Closed access
SKSharon Kehoe
Sharon Kehoe
XZX.F. Zhang
X.F. Zhang
LLL. Lewis
L. Lewis
HOH. O'SHea
H. O'SHea
DBD. Boyd
D. Boyd

Verified
Journal Article
Open access
PDF file
SKSharon Kehoe
Sharon Kehoe
MTMarie-Laurence Tremblay
Marie-Laurence Tremblay
ACAisling Coughlan
Aisling Coughlan
MTMark Towler
Mark Towler
JRJan Rainey
Jan Rainey
DBDaniel Boyd
Daniel Boyd
Experimental embolic particles based on a novel zinc-silicate glass system have been biologically evaluated for potential consideration in transcatheter arterial embolization procedures. In addition to controlling the cytotoxicity and haemocompatibility for such embolic particles, its glass structure may mediate specific responses via dissolution in the physiological environment. In a 120 h in-vitro dissolution study, ion release levels for silicon (Si4+), sodium (Na+), calcium (Ca2+), zinc (Zn2+), titanium (Ti4+), lanthanum (La3+), strontium (Sr2+), and magnesium (Mg2+), were found to range from 0.04 to 5.41 ppm, 0.27–2.28 ppm, 2.32–8.47 ppm, 0.16–0.20 ppm, 0.12–2.15 ppm, 0.16–0.49 ppm and 0.01–0.12 ppm, respectively for the series of glass compositions evaluated. Initial release of Zn2+ (1.93–10.40 ppm) was only evident after 120 h. All compositions showed levels of cell viabilities ranging from 61.31 ± 4.33% to 153.7 ± 1.25% at 25%–100% serial extract dilutions. The conformational state of fibrinogen, known to induce thrombi, indicated that no changes were induced with respect of the materials dissolution by-products. Furthermore, the best-in-class experimental composition showed equivalency to contour PVA in terms of inducing platelet adhesion. The data generated here provides requisite evidence to continue to in-vivo pre-clinical evaluation using the best-in-class experimental composition evaluated.